The good news: The lenses affected can be replaced with artificial lens implants by way of an uncomplicated surgical intervention. In the U.S. alone, the number of cataract operations performed each year has now reached close to 3 million.
ZEISS technology provides support to physicians performing the surgery. The company makes an innovative device used to remove the diseased lens: Visalis 100 utilizes the phaco-emulsification procedure with ultrasound and vacuum suction to remove the lenses. ZEISS offers a complete program of solutions for the treatment of cataracts ranging from diagnostic devices to intraocular lenses and surgical microscopes to after-care systems.
The new Visalis 100 system is already being used by surgeons in India. It features impressive ease of use and absolute precision - innovations which are in high demand in the emerging markets and especially in Asia, where innumerable surgical procedures on the eyes are performed each day. ZEISS is a sponsor of Vision 2020 – The Right to Sight Project, underscoring the company’s commitment to the fight against preventable blindness and the fostering of ophthalmology in regions where medical care is scarce.